We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$9.45B
AUM Growth
+$719M
Cap. Flow
+$643M
Cap. Flow %
6.8%
Top 10 Hldgs %
29.09%
Holding
237
New
15
Increased
96
Reduced
78
Closed
21

Top Buys

Rank Stock Value
1
ACCD
Accolade Inc
ACCD
+$56.6M
2
RVMD icon
Revolution Medicines
RVMD
+$46M
3
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$43.7M
4
EPIX
ESSA Pharma
EPIX
+$42.4M
5
BDX icon
Becton Dickinson
BDX
+$33.4M

Top Sells

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$86.9M
2
HALO icon
Halozyme
HALO
+$47.2M
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$38.1M
4
ESPR
Esperion Therapeutics
ESPR
+$33.9M
5
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$33.3M

Sector Composition

Rank Sector Weight
1 Healthcare 95.93%
2 Industrials 0.88%
3 Technology 0.47%
4 Consumer Discretionary 0.04%
5 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYNH
151
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.44M 0.02%
+19,000
New +$1.43M
YI
152
111 Inc
YI
$1.17M 0.01%
+8,500
New +$1.24M
QURE icon
153
uniQure
QURE
$2.68B
$1.16M 0.01%
34,500
– –
JMIA
154
Jumia Technologies
JMIA
$726M
$638K 0.01%
+18,000
New +$862K
KOS icon
155
Kosmos Energy
KOS
$1.56B
$599K 0.01%
195,000
-230,000
-54% -$671K
MKC icon
156
McCormick & Company Non-Voting
MKC
$13.4B
$526K 0.01%
5,900
+1,500
+34% +$133K
RDY icon
157
Dr. Reddy's Laboratories
RDY
$9.82B
$522K 0.01%
42,500
– –
OPT
158
DELISTED
Opthea Limited American Depositary Shares
OPT
$483K 0.01%
50,000
– –
MCK icon
159
McKesson
MCK
$98.5B
$474K 0.01%
2,430
– –
MKL icon
160
Markel Group
MKL
$25B
$456K ﹤0.01%
400
– –
SPGI icon
161
S&P Global
SPGI
$126B
$423K ﹤0.01%
1,200
– –
FTNT icon
162
Fortinet
FTNT
$112B
$406K ﹤0.01%
11,000
-3,500
-24% -$115K
LYV icon
163
Live Nation Entertainment
LYV
$41.2B
$398K ﹤0.01%
4,700
-1,500
-24% -$121K
TCOM icon
164
Trip.com Group
TCOM
$27.5B
$396K ﹤0.01%
10,000
-3,100
-24% -$115K
EL icon
165
Estee Lauder
EL
$29B
$392K ﹤0.01%
1,348
-900
-40% -$246K
CLX icon
166
Clorox
CLX
$11.6B
$386K ﹤0.01%
2,000
– –
SWKS icon
167
Skyworks Solutions
SWKS
$9.06B
$385K ﹤0.01%
2,100
-700
-25% -$122K
TW icon
168
Tradeweb Markets
TW
$21.3B
$385K ﹤0.01%
5,200
-1,600
-24% -$110K
IT icon
169
Gartner
IT
$9.41B
$383K ﹤0.01%
2,100
-1,300
-38% -$226K
PAYX icon
170
Paychex
PAYX
$40.4B
$382K ﹤0.01%
3,900
-1,500
-28% -$138K
KMX icon
171
CarMax
KMX
$8.27B
$378K ﹤0.01%
+2,850
New +$347K
BKNG icon
172
Booking.com
BKNG
$138B
$373K ﹤0.01%
4,000
-1,000
-20% -$88.8K
MCO icon
173
Moody's
MCO
$81.7B
$373K ﹤0.01%
1,250
-250
-17% -$70.4K
TRMB icon
174
Trimble
TRMB
$12.3B
$373K ﹤0.01%
4,800
-3,500
-42% -$253K
AXP icon
175
American Express
AXP
$223B
$368K ﹤0.01%
2,600
-1,000
-28% -$132K
5 6
7
8 9

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

Bellevue Group's Q1 2021 Portfolio in Review

As of Q1 2021, Bellevue Group held 237 positions worth $9.45B, up 8.2% from $8.73B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bellevue Group deployed $643M of net new capital in Q1 2021, opening 15 new positions and adding to 96 existing holdings. Its largest new stake was ESSA Pharma: 1,825,814 shares worth $53M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was GW Pharmaceuticals Plc American Depositary Shares, an estimated $86.9M trimmed.

  • Bellevue Group's largest Q1 2021 buy was ESSA Pharma: 1,825,814 shares worth $53M.
  • Bellevue Group added most to Accolade Inc in Q1 2021, an estimated $56.6M increase.
  • Bellevue Group's biggest Q1 2021 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $86.9M.
  • Bellevue Group fully exited GenMark Diagnostics, Inc in Q1 2021, selling an estimated $38.1M.
  • Bellevue Group's ten largest holdings make up 29% of its $9.45B portfolio in Q1 2021.
  • Bellevue Group opened 15 new positions and closed 21 in Q1 2021.
  • Bellevue Group's portfolio value rose 8.2% quarter-over-quarter to $9.45B.

Based on Bellevue Group's 13F filing for Q1 2021, filed 12 May 2021.